Execs On The Move, February 2021
Executive Summary
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
You may also be interested in...
Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
Sanofi Backs Novadiscovery In Silico Trial Platform
Novadiscovery has received funding from Sanofi and will support the French major’s COVID-19 efforts with its virtual JINKO clinical trial platform.
Avacta/Daewoong’s Joint-Venture AffyXell Paves Way For Next-Generation Stem Cell Therapy
A new joint venture from Avacta and Daewoong Pharmaceutical aims to use novel mesenchymal stem cells to secrete antibody mimetic "Affimers" to treat inflammatory diseases.
Need a specific report? 1000+ reports available
Buy Reports